In colorectal carcinoma cells, reducing Bok levels led to cell cycle arrest through increased p19INK4d, p21cip1, and p53 upregulation, with p53 absence nullifying Bok-driven effects [95, 96]. The gene discussed is TP53; the disease is colorectal carcinoma.